Opportunity ID: 306618

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-AG-19-011
Funding Opportunity Title: Integrative Omics to Enhance Therapeutics Development for Healthy Aging (UH2/UH3 Clinical Trial Not Allowed)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 1
Assistance Listings: 93.866 — Aging Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Jun 27, 2018
Last Updated Date:
Original Closing Date for Applications: Nov 14, 2018
Current Closing Date for Applications: Nov 14, 2018
Archive Date: Dec 20, 2018
Estimated Total Program Funding: $5,000,000
Award Ceiling: $3,300,000
Award Floor:

Eligibility

Eligible Applicants: Native American tribal governments (Federally recognized)
City or township governments
Private institutions of higher education
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Native American tribal organizations (other than Federally recognized tribal governments)
State governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
County governments
Independent school districts
For profit organizations other than small businesses
Special district governments
Public and State controlled institutions of higher education
Small businesses
Public housing authorities/Indian housing authorities
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description: This Funding Opportunity Announcement (FOA) is a phased innovation initiative to facilitate multi-omics/integrative approaches to identify omics profiles associated with protection against multiple aging conditions, with exceptional health span, and to refine strategies for utilizing these profiles for therapeutics development. Specifically, a phased innovation cooperative agreement mechanism (UH2/UH3) involving an interdisciplinary research team will be used to support a single project that will conduct integrative analysis of person -specific multiple omics measurements (e.g., transcriptomics, proteomics, metabolomics) generated across multiple tissues ; the multi-omic profiling should be conducted on individuals from extensively phenotyped cohorts with substantial numbers of long-lived individuals with characteristics of exceptionally healthy aging and appropriate controls. It will also: 1) harmonize and extend the use of existing phenotypic data from these studies to apply phenomics to transcriptomic, proteomic, metabolomic findings, 2) select animal model species or strains with varying life spans for comparative omics studies and identify potential determinants of species differences in longevity and rates of disease development, 3) develop appropriate computational and analytical tools to identify omics profiles associated with exceptional longevity and healthy aging, 4) apply translational bioinformatics approaches and leverage existing publicly available drug signatures databases to identify molecules that could produce profiles associated with exceptionally healthy aging and 5) exchange data with other NIH/NIA-supported related omics activities and other public-private partnerships (e.g., Trans-Omics for Precision Medicine (TOPMed), Accelerating Medicines Partnership- Alzheimers Disease (AMP-AD) for data harmonization and analysis.
Link to Additional Information: http://grants.nih.gov/grants/guide/rfa-files/RFA-AG-19-011.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email: FBOWebmaster@OD.NIH.GOV

Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-E FORMS-E PKG00243420 Oct 14, 2018 Nov 14, 2018 View

Package 1

Mandatory forms

306618 RR_SF424_2_0-2.0.pdf

306618 PHS398_CoverPageSupplement_4_0-4.0.pdf

306618 RR_OtherProjectInfo_1_4-1.4.pdf

306618 PerformanceSite_2_0-2.0.pdf

306618 RR_KeyPersonExpanded_2_0-2.0.pdf

306618 RR_Budget_1_4-1.4.pdf

306618 PHS398_ResearchPlan_4_0-4.0.pdf

Optional forms

306618 RR_SubawardBudget30_1_4-1.4.pdf

306618 PHS_AssignmentRequestForm_2_0-2.0.pdf

2025-07-09T16:26:32-05:00

Share This Post, Choose Your Platform!

About the Author: